Frontiers in Oncology, 2023 · DOI: 10.3389/fonc.2023.1239636 · Published: December 12, 2023
This study evaluates the use of 3D-printed boluses in breast cancer patients undergoing breast reconstruction and postmastectomy radiotherapy (PMRT) to improve dose distribution and reduce skin toxicities. The 3D-printed bolus ensures adequate dose coverage to the chest wall while minimizing the dose to organs at risk (OARs), leading to acceptable skin toxicity levels. The 3D-printed bolus provides better conformance to the chest wall compared to traditional boluses, reducing air gaps and improving dose uniformity.
3D-printed boluses can provide more uniform radiation dose distribution to the chest wall, ensuring better treatment efficacy.
The use of 3D-printed boluses can help in controlling and minimizing skin toxicities associated with PMRT.
The individualized nature of 3D-printed boluses allows for a more precise radiotherapy strategy for patients undergoing breast reconstruction and PMRT.